Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
It is suitable for infections caused by single or multiple bacteria sensitive to meropenem in adults and children, including pneumonia, urinary tract infections, and gynecological infections.
Market Analysis and Insights: Global Meropenem Injection Market
Due to the COVID-19 pandemic, the global Meropenem Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 0.25g/vial accounting for % of the Meropenem Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Meropenem Injection market size is valued at US$ million in 2021, while the US and Europe Meropenem Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Meropenem Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Meropenem Injection include Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Fresenius Kabi, Mylan, Sagent Pharmaceuticals and Bionova Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Meropenem Injection Scope and Segment
Meropenem Injection market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Meropenem Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
0.25g/vial
0.5g/vial
1g/vial
Segment by Application
Hospital
Clinics
Others
By Company
Pfizer
AuroMedics
Sandoz
Amneal Pharmaceuticals
Sumitomo Dainippon Pharma
Fresenius Kabi
Mylan
Sagent Pharmaceuticals
Bionova Scientific
Macleods Pharmaceuticals
Johnlee Pharmaceuticals
Xinya Pharm
PKU HealthCare
United Laboratories
CSPC Group
Zhejiang Hisun Pharmaceutical
Luoxin Pharmaceutical
Hainan Haiyao Co., Ltd.
Shenzhen Haibin Pharmaceutical
Chongqin Shenghuaxi
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Market Analysis and Insights: Global Meropenem Injection Market
Due to the COVID-19 pandemic, the global Meropenem Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 0.25g/vial accounting for % of the Meropenem Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Meropenem Injection market size is valued at US$ million in 2021, while the US and Europe Meropenem Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Meropenem Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Meropenem Injection include Pfizer, AuroMedics, Sandoz, Amneal Pharmaceuticals, Sumitomo Dainippon Pharma, Fresenius Kabi, Mylan, Sagent Pharmaceuticals and Bionova Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Meropenem Injection Scope and Segment
Meropenem Injection market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Meropenem Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
0.25g/vial
0.5g/vial
1g/vial
Segment by Application
Hospital
Clinics
Others
By Company
Pfizer
AuroMedics
Sandoz
Amneal Pharmaceuticals
Sumitomo Dainippon Pharma
Fresenius Kabi
Mylan
Sagent Pharmaceuticals
Bionova Scientific
Macleods Pharmaceuticals
Johnlee Pharmaceuticals
Xinya Pharm
PKU HealthCare
United Laboratories
CSPC Group
Zhejiang Hisun Pharmaceutical
Luoxin Pharmaceutical
Hainan Haiyao Co., Ltd.
Shenzhen Haibin Pharmaceutical
Chongqin Shenghuaxi
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
